Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan
Clinical trial NCT03143166 · COMPLETED
Trial details
- NCT number
- NCT03143166
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-22
- Primary completion
- 2017-07-27
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.